The effectiveness of adalimumab in the treatment of ulcerative colitis is under debate. Although controlled trials have shown that adalimumab is significantly better than placebo, the absolute clinical benefit is modest. We report data on the effectiveness of adalimumab in a cohort of ulcerative colitis patients treated in 22 Italian centres.

Adalimumab in active ulcerative colitis: a "real-life" observational study / Paolo, Gionchetti; Fernando, Rizzello. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - STAMPA. - 45:9(2013), pp. 738-743. [10.1016/j.dld.2013.03.018]

Adalimumab in active ulcerative colitis: a "real-life" observational study.

GIONCHETTI, PAOLO;RIZZELLO, FERNANDO
2013

Abstract

The effectiveness of adalimumab in the treatment of ulcerative colitis is under debate. Although controlled trials have shown that adalimumab is significantly better than placebo, the absolute clinical benefit is modest. We report data on the effectiveness of adalimumab in a cohort of ulcerative colitis patients treated in 22 Italian centres.
2013
Adalimumab in active ulcerative colitis: a "real-life" observational study / Paolo, Gionchetti; Fernando, Rizzello. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - STAMPA. - 45:9(2013), pp. 738-743. [10.1016/j.dld.2013.03.018]
Paolo, Gionchetti; Fernando, Rizzello
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/399819
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 67
  • ???jsp.display-item.citation.isi??? 63
social impact